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ARDS Pathophysiology
Introduction
In the 1960’s, military physicians discovered a distinct hypoxic condition involving both
lungs simultaneously (Modrykamien & Gupta, 2015). In Vietnam, this condition was
referred to by physicians as “shock lung”. Meanwhile, civilian physicians who
encountered this condition termed it adult respiratory distress syndrome. The term was
later modified to acute respiratory distress syndrome (ARDS) after determining that similar
cases existed among all age groups (Modrykamien & Gupta, 2015).
ARDS develops after insult to the lung tissue. There are many conditions that can
precipitate such an injury. Some of the more common precipitating factors include:
•
Sepsis
•
Aspiration
•
Pneumonia
•
Pancreatitis
•
Trauma (Hansen-Flaschen &Siegel, 2016)
Despite advances in treatment of ARDS, incidence and mortality remain high. In the
United States, ARDS has an estimated incidence of 190,000 cases per year and a mortality
rate of 26% to 58% (Modrykamien & Gupta, 2015). In a recent study, ARDS represented
10.4% of total intensive care unit (ICU) admissions and 23.4% of all patients requiring
mechanical ventilation. (Bellani et al., 2016).

(Image retrieved from https://www.homeofpoi.com/us/lessons/teach/Firebreathers-Lungor-ARDS-11x52x198)

Signs and Symptoms
In order to meet the Berlin definition of ARDS, certain criteria must be met, including:
•
an acute onset of hypoxemia
•
radiographic imaging showing bilateral pulmonary infiltrates
•
the event is not cardiogenic in nature (Hansen-Flaschen &Siegel,
2016).

Nursing Implications

Tissue Injury
Normally, physical barriers including endothelial and epithelial cell layers, the basement
membrane, and the extracellular matrix help healthy lungs maintain dry alveoli by
regulating the passage of fluid from the pulmonary capillaries to the alveoli (Fujishima,
2014). Tissue injury disrupts this process and results in severe negative consequences,
including:
•

Destruction of the microvascular make-up allows leakage of blood products and
proteins from the capillaries to the alveoli (Fujishima, 2014).

•

With proteins leaking out of the capillaries, the oncotic gradient no longer favors
reabsorption of fluid into the intravascular space (Hansen-Flaschen & Siegel, 2016).

•

The flood of exudate into the airspace perpetuates tissue injury leading to a further
release of pro-inflammatory cytokines (Hansen-Flaschen & Siegel, 2016).

Conclusion
(Image retrieved from http://www.slideshare.net/subodhchaturvedi1/ventillation-strategies-inards)

The innate immune system plays a major role in the dysregulation of the inter- and
intracellular molecules that increase vascular permeability and subsequent tissue damage,
particularly the stimulation of alveolar macrophages and neutrophils. Once stimulated,
macrophages recruit neutrophils and circulating macrophages to the site of injury where
they perpetuate the inflammatory response by promoting the release of biochemical
mediators such as, proteases, reactive oxygen species, eicosanoids, phospholipids, and
cytokines (Han & Mallampalli, 2015).

Significance of Pathophysiology

These cytotoxic molecules cause tissue necrosis as well as the induction of distal cell
death, including the destruction of type II epithelial cells. This is of particular importance
since type II epithelial cells are responsible for making surfactant, a substance that lines
the alveoli, lowers surface tension and prevents alveolar collapse (Han & Mallampalli,
2015). Some of the inflammatory cytokines that are shown to be elevated in ARDS
patients include IL-1B, TNF-a, IL-6, and IL-8. Also of note is the research into pattern
recognition receptors (PRRs) and their involvement in the development of ARDS.
Particularly the toll-like receptor (TLR) signaling pathway. It’s believed that hyaluronan,
an extracellular matrix of glycosaminoglycan produced after tissue injury, initiates the
inflammatory response in ARDS through TLR2 and TLR4 (Han & Mallampalli, 2015).

Impaired Gas Exchange
Damage to the endothelium allows a type of exudate into the lung parenchyma and eventually
the alveolar airspace (Marino, 2014). The increased lung weight causes dependent zones of
the lungs to collapse, leaving only non-dependent areas to remain open for ventilation
(Gattinoni & Quintel, 2016). The resulting shunt from the increased gasless areas and reduced
lung size are the cause of the characteristic refractory hypoxemia seen in ARDS (Gattinoni &
Quintel, 2016).

Decreased Lung Compliance
Decreased lung compliance is a result of the activation of the coagulation cascade during the
acute inflammatory process. It is triggered by the release of tissue factor from the damaged
lungs (Marino, 2014). During the process, fibrin deposits form in the lungs and can undergo
remodeling to produce pulmonary fibrosis (Marino, 2014). The fibrous tissue, combined with
collapsed alveoli, decrease the compliance of the lungs and result in progressive respiratory
insufficiency.

Increased Pulmonary Artery Pressure
Increased pulmonary artery pressure is another significant consequence of the ARDS
pathophysiology. It may be caused by hypoxic vasoconstriction, positive pressure ventilation,
parenchymal destruction, airway collapse, and hypercarbia (Siegel, 2016). Although cor
pulmonale is rare, right ventricular dysfunction associated with pulmonary hypertension
increases the mortality of ARDS (Nagelhout & Plaus, 2014).

eventual respiratory failure (Hansen-Flaschen &Siegel, 2016).

In addition to the symptoms related to respiratory distress and subsequent respiratory
failure, ARDS patients will typically display symptoms of the precipitating disease process
as well.

ensure optimal therapy.

The Innate Immune System and Inflammation

The signs and symptoms of ARDS are related to these findings and include:
•
dyspnea
•
cyanosis
•
diffuse crackles (Hansen-Flaschen &Siegel, 2016)
•
arterial blood gas revealing hypoxemia
•

These patients are typically going to require
intensive care. It is the duty of the ICU
nursing staff to understand the progression,
treatment, and potential complications of
this disease. The ARDS patient can be
incredibly complex, requiring some of the
most advanced therapy and equipment seen
in the ICU, including, advanced ventilator
management, pronation beds, advanced
hemodynamic monitoring, vasoactive
medications, and neuromuscular blocking
agents (Modrykamien & Gupta, 2015). Of
course, the ICU nurse cannot be expected to
manage these patients alone. They must be
adept in working as part of an
interdisciplinary team, able to collaborate
with physicians, respiratory therapists, and
other members of the treatment team to

The pathophysiology of ARDS primarily involves an initial lung injury followed by
mechanisms that increase pulmonary microvascular permeability and perpetuate further
injury. The innate immune system and the inflammation process are key factors in this
process (Fujishima, 2014).

(Images retrieved from https://quizlet.com/20888959/pathophysiology-26-pulmonaryobjectives-2356-flash-cards/)

As of now, the only treatment for ARDS is
supportive care aimed at improving gas
exchange. The standard of care is lung
protective ventilation strategies including
low-tidal volumes and utilization of positive
end expiratory pressure (PEEP). As well as
the use of more aggressive strategies
including neuromuscular blockers and
prone positioning. Although these therapies
are currently the only treatments shown to
improve mortality, efforts are being made to
identify treatments aimed at modulating the
inflammatory response.
It is the responsibility of the nurse, and the
rest of the treatment team, to be aware of
the disease process, associated
complications, and the most up to date
therapy options. As a team, the various
disciplines can utilize their expertise to
optimize the patients’ ventilation status
while treating the underlying cause. With a
deeper understanding of the
pathophysiologic process of ARDS,
clinicians can better implement treatment
plans to improve patient mortality.
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